Home » Newsletters » BioWorld

BioWorld

May 12, 1993

View Archived Issues

FDA APPROVES RIBI IND

ALEX. BROWN CONFERENCE: XOMA FOCUSES ON BPI

ALEX. BROWN CONFERENCE: SCHERING TO MARKET ETHYOL IN EUROPE

ALEX. BROWN CONFERENCE: VESTAR PLANS TRIAL ON TB DRUG

QUIDEL TO COLLABORATE WITH EPITOPE

ALEX. BROWN CONFERENCE: SHAMAN TO TEST HERPES DRUG

CANTAB SIGNS PACT WITH OXFORD

GI, AMGEN RESOLVE EPO PATENT DISPUTE

NEORX BEGINS TRIAL FOR MANUFACTURER

BIOSYS BUYS PHEROMONE COMPANY

ALEX. BROWN CONFERENCE: 'HILLARY WOULD LOVE THIS'

ALEX. BROWN CONFERENCE: AMYLIN VS. DIABETES

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 6, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...